• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Syncona Limited

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund Provider BACIT Limited
Fund Summary The Company?s investment objective is to achieve superior long-term capital appreciation from its investments. The Company may invest in: life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments) and leading long-only and alternative investment funds and managed accounts across multiple asset classes (Fund Investments).The Company will target an annualised return per share across its investment portfolio of 15 per cent per annum over the long-term. The Company is not required to allocate a specific percentage of its assets to Life Science Investments or Fund Investments although it is intended that the Company should invest the significant majority of its assets in Life Science Investments. The Company anticipates that it will, in general, invest available cash in Fund Investments and realise those investments as and when finance is required for its Life Science Investments.
SEDOL code B8P59C0
Fund code BACTL
Managers Arabella Cecil
Manager Tenure 7 years
Morningstar Category Alt - Fund of Funds - Multistrategy
Fund Size Currently unavailable
Fund Type ETF / IT
Management Style Active
Total Expense Ratio (TER) 1.28%
Cavendish ongoing charge 0.05%
FundsNetwork Service Fee 0.20%
Minimum Initial Investment £25
Minimum Top Up £25
Minimum Monthly Investment £25
Sell Price £2.33
Buy Price £2.345
Price Change -1.8947%
Price Date 15th July 2019
Yield Currently unavailable
Dividend Frequency Yearly
ISA Eligible Yes
SIPP Eligible Yes
Inception Date 26th October 2012
Fund Status OPEN

3-year Mean Monthly Return: Currently unavailable

Annual Returns 2018 2017 2016 2015 2014 2013
Fund Performance +45.53% +14.84% +12.71% -1.72% +11.62% +4.56%
Benchmark Performance
(Alt - Fund of Funds - Multistrategy)
Time Period Cumulative Benchmark Performance
(Alt - Fund of Funds - Multistrategy)
Fund Compared to Benchmark
1 day -2.52% +0.12% Currently unavailable
1 week 5.20% -0.37% Currently unavailable
1 month -0.07% +1.47% Currently unavailable
3 months -9.67% +2.00% Currently unavailable
6 months -7.36% +3.11% Currently unavailable
1 year -11.04% +3.31% Currently unavailable
3 years 82.48% +11.18% Currently unavailable
5 years 104.52% +12.40% Currently unavailable
10 years Currently unavailable +36.26% Currently unavailable
YTD -12.21% +2.35% Currently unavailable
Since inception 146.12% Currently unavailable Currently unavailable

Top 10 shares for this fund

Share Name Country Value
Blue Earth Diagnostics 17.45%
Nightstar Therapeutics Ltd ADR GBR 11.62%
Autolus 7.95%
Companies Of Less Than 1% Of Nav 4.79%
The SFP Value Realization Fund Ltd USD CYM 3.52%
Polar Capital UK Absolute Eq I EUR IRL 3.44%
Freeline Therapeutics 3.36%
Funds Of Less Than 1% Of Nav 3.08%
Maga Smaller Companies UCITS EUR Acc IRL 2.96%
Polygon European Equity Opportunity Fund 2.95%
Dividend Date Per share amount Reinvestment Price
20th June 2019 0.0230 £228.0000
21st June 2018 0.0230 £225.0000
20th July 2017 0.0230 £172.4000
14th July 2016 0.0220
16th July 2015 0.0210
6th August 2014 0.0200